ÂÜÀòÂÒÂ×

Mr. James Miskel holds management responsibility for ICON’s central laboratories, specialty laboratories, bioanalytical laboratories, and early clinical development services. He joined ICON with an initial focus on central laboratories in November 2013, after executive positions in general and operations management at Wyeth Pharmaceuticals and CROs MDS Pharma Services and Harlan Laboratories. Mr. Miskel spent his early career as a management consultant with McKinsey & Company leading engagements in growth strategy, operational improvement, and merger integration for clients in pharmaceuticals, medical devices, and several other sectors. He holds BS and MS degrees in engineering from the Massachusetts Institute of Technology along with an MBA from the Wharton School and an MA in International Studies from the University of Pennsylvania.